跳至主要内容
临床试验/NCT02140021
NCT02140021终止不适用

Prevalence of Anal Dysplasia and Anal Cancer in Women With Cervical, Vaginal and Vulvar Dysplasia and Cancer

M.D. Anderson Cancer Center4 个研究点 分布在 1 个国家目标入组 409 人开始时间: 2014年10月27日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
409
试验地点
4
主要终点
Sensitivity and specificity of anal pap testing to diagnose anal dysplasia

研究概览

简要总结

This trial studies the prevalence of anal dysplasia and anal cancer in patients with cervical, vaginal, and vulvar dysplasia and cancer. Studying samples collected from patients in the laboratory may help doctors learn more about the human papillomavirus and how often anal cancer occurs in patients with cervix, vagina, or vulvar cancer.

详细描述

PRIMARY OBJECTIVES:

I. To estimate the prevalence of invasive squamous cell carcinoma of the anus in women with high-grade dysplasia or carcinoma of the cervix, vagina or vulva.

SECONDARY OBJECTIVES:

I. To estimate the prevalence of anal dysplasia in women with high-grade dysplasia or carcinoma of the cervix, vagina or vulva.

EXPLORATORY OBJECTIVES:

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with histologically confirmed cervical, vaginal or vulvar high-grade dysplasia, invasive squamous cell carcinoma, invasive adenocarcinoma, or adenocarcinoma-in-situ (AIS). All stages and grades will be eligible.
  • Women with a diagnosis of high grade intraepithelial lesion (HSIL) from a routine pap test.
  • Patients must sign an approved informed consent document.

排除标准

  • Patients with previously documented perianal squamous cell dysplasia or invasive squamous cell carcinoma of the anus or anal canal.
  • Patients unwilling or unable to provide informed consent for the study.
  • Male patients will not be included in this study.
  • Patients with previously documented HPV related oropharyngeal cancer.

结局指标

主要结局

Sensitivity and specificity of anal pap testing to diagnose anal dysplasia

时间窗: Up to 5 years

Will use the results of anoscopy as the true state of the patient and will estimate with 95% confidence intervals.

Sensitivity and specificity of anal human papillomavirus (HPV) testing to diagnose anal dysplasia

时间窗: Up to 5 years

Will use the results of anoscopy as the true state of the patient and will estimate with 95% confidence intervals.

Prevalence of invasive squamous cell carcinoma of the anus

时间窗: Up to 5 years

Will estimate the prevalence of invasive squamous cell carcinoma of the anus in women with 95% confidence intervals.

Sensitivity and specificity of the combination of anal pap testing + anal HPV testing to diagnose anal dysplasia

时间窗: Up to 5 years

Will use the results of anoscopy as the true state of the patient and will estimate with 95% confidence intervals.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验